BioCentury
ARTICLE | Clinical News

CERC-501: Completed Phase II enrollment

September 12, 2016 7:00 AM UTC

Cerecor completed enrollment of 71 heavy cigarette smokers who are not seeking treatment for tobacco use disorder in a double-blind, placebo-controlled, 2-way crossover, U.S. Phase II trial evaluating...